GT Biopharma, Inc. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GT Biopharma, Inc. annual/quarterly Interest Expense history and growth rate from 2010 to 2023.
  • GT Biopharma, Inc. Interest Expense for the quarter ending June 30, 2023 was $1K.
  • GT Biopharma, Inc. annual Interest Expense for 2023 was $213K, a 2563% increase from 2022.
  • GT Biopharma, Inc. annual Interest Expense for 2022 was $8K, a 98.9% decline from 2021.
  • GT Biopharma, Inc. annual Interest Expense for 2021 was $718K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $213K +$205K +2563% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $8K -$710K -98.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $718K +$3.72M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$3M -$875K -41.1% Jan 1, 2020 Dec 31, 2020 10-K 2021-04-16
2019 -$2.13M -$11.2M -123% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-16
2018 $9.12M +$515K +5.99% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $8.6M +$2.05M +31.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $6.56M -$10.5M -61.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 $17M +$11.9M +231% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
2014 $5.15M +$3.95M +330% Jan 1, 2014 Dec 31, 2014 10-K/A 2018-02-28
2013 $1.2M -$457K -27.6% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $1.65M +$1.1M +197% Jan 1, 2012 Dec 31, 2012 10-K 2015-01-08
2011 $556K +$43K +8.38% Jan 1, 2011 Dec 31, 2011 10-K 2014-11-18
2010 $513K Jan 1, 2010 Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.